Walleye Capital’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-150,503
| Closed | -$1.53M | – | 2107 |
|
|
2025
Q1 | $1.53M | Sell |
150,503
-47,163
| -24% | -$481K | 0.01% | 698 |
|
|
2024
Q4 | $3.13M | Buy |
+197,666
| New | +$3.13M | 0.01% | 563 |
|
|
2023
Q2 | – | Sell |
-67,636
| Closed | -$2.89M | – | 2489 |
|
|
2023
Q1 | $2.89M | Buy |
67,636
+58,833
| +668% | +$2.51M | 0.04% | 417 |
|
|
2022
Q4 | $423K | Sell |
8,803
-8,655
| -50% | -$416K | 0.01% | 1060 |
|
|
2022
Q3 | $657K | Sell |
17,458
-22,642
| -56% | -$852K | 0.01% | 913 |
|
|
2022
Q2 | $1.11M | Buy |
40,100
+11,054
| +38% | +$305K | 0.03% | 580 |
|
|
2022
Q1 | $1.58M | Buy |
+29,046
| New | +$1.58M | 0.04% | 424 |
|